Economic slowdown: Festival sales dip 40% in retail stores, footfall down 60%

Agencies
October 24, 2019

New  Delhi, Oct 24: As a consumption slowdown grips the economy, even festival season sales (September-October) have taken a massive hit this year, with sales down around 40 per cent compared to a year-ago period.

The Secretary General of the Confederation of All India Traders (CAIT) says the major reasons for decline in sales are cash crunch of consumers and the mass shift to the online markets on the back of "deep" discounts. Speaking to IANS, he said that the footfall in the brick and mortar shops including malls has taken a hit by around 60 per cent in comparison to last year

He was however, of the view that sales may witness a spike on 'Dhanteras', October 25.

"So far in comparison to last year, sales are down 40 per cent (during the festival season). Although traders have lost every hope, the jewellery sector feels, may be 'Dhanteras' would help jewellery along with utensils and kitchen equipment sales," Khandelwal said.

He also noted that the overall sentiment in the market is marked by "slowdown".

Further, as per Khandelwal, most of the retailers did not even fill their inventory ahead of the festival season, as done traditionally.

"People have not increased their inventory this year for the festival season. Generally, traders fill their inventory before two months, with a hope that the sales will rise, as prices then remain subdued," he said.

Referring to the lack of sales, he mentioned that around 70 per cent investment by retailers on inventory for Diwali has become "dead" investment.

Consumption slowdown in the country has been witnessed over the last few quarters. Although the government off late has announced a slew of measures to enhance liquidity and boost demand, so far the steps have not born fruit.

Khandelwal also puts a significant part of the blame of decline in offline retail sales on the heavy discounts on the online platforms.

Although the offline market is going through a lean phase despite festivals, major online platforms claim significant rise in sales during their festival sales whereby they offer discounts and offers.

CAIT has been protesting against the "deep discounts" for long and has recently asked the government to check whether the online platforms violate the norms for foreign direct investment (FDI).

Following which the government has sought replies from the major platforms with FDI regarding the allegations.

Despite the gloomy situation, there are instances of market players reporting a rise in their offline sales.

Lalit Agarwal, Chairman and Managing Director, V-Mart Retail said: "We have seen decent growth in sales during the festive season. When we talk about online retailers, the majority of their sales come from mobile phones and it didn't have an impact on our sales in small towns. We will continue to see growth in sales since marriages will start which means festive season will continue even after October."

By and large, the economy which is going through a prolonged phase of low demand and consumption across sectors would take some more time to revive and the retail sector might have to be patient for the return of the consumers and sales in good numbers.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 27,2020

New Delhi, Mar 27: Prime Minister Narendra Modi on Friday described British premier Boris Johnson as a "fighter" and hoped he recovers from coronavirus infection.

"Dear PM @BorisJohnson, you're a fighter and you will overcome this challenge as well," Modi tweeted.

He said he prays for his good health and extends best wishes in ensuring a healthy UK.

Johnson said on Friday that he has tested positive for coronavirus after experiencing mild symptoms and is now self-isolating at 10 Downing Street in line with the medical advice.

"I am now self-isolating, but I will continue to lead the government's response via video-conference as we fight this virus," he said.

Comments

Kannadiga
 - 
Friday, 27 Mar 2020

Fit for only bogus comments and not  for countrymens welfare. A present we all can see Kerala CMs action and program. Each and every one has to salute him i/o  Taal Bajao foolinesh.

 

 

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 29,2020

New Delhi, Jan 29: The Supreme Court on Wednesday dismissed the plea by Mukesh Kumar Singh, one of the four death row convicts in the Nirbhaya gang rape and murder case, challenging the rejection of his mercy petition by the President.

A three-judge bench headed by Justice R Banumathi said that expeditious disposal of mercy plea by the President doesn't mean non-application of mind by him.

The court also said that alleged sufferings in prison can't be grounds to challenge the rejection of mercy petition.

The bench said all relevant material including judgments pronounced by trial court, high court and Supreme Court were placed before the President when he was considering the mercy plea of the convict.

The bench also comprising justices Ashok Bhushan and A S Bopanna rejected the contentions of the counsel appearing for Singh that entire materials of the case were not placed before the President when he was considering his mercy plea.

The bench, while referring to two files placed before it by the Centre on Tuesday, said that as per the January 15 covering letter which was sent by the Delhi government to the Ministry of Home Affairs, all relevant documents were sent.

The bench noted that detailed judgements of trial court, high court and the Supreme Court, curative petition filed by Singh, his past criminal history and his family background were sent to the Home Ministry by the Delhi government.

"All the documents were taken into consideration by the President while rejecting the mercy petition," the bench said.

The bench also dealt with submissions advanced by the convict's counsel, who had argued that the mercy plea was rejected at "lightning speed".

The bench said that if a mercy petition is expeditiously dealt with, it cannot be assumed that it has been adjudicated upon in a pre-conceived mind.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.